Targeted Therapy and Chemotherapy: Understanding the Difference
Direct Answer:Targeted Therapy and Chemotherapy are two fundamental approaches used in cancer treatment, but they work in very different ways. […]
Precision Oncology
Geriatric & AYA Oncology
Fertility After Cancer Treatment: What Survivors Need to Know
Many cancer survivors retain the possibility of having children after treatment, although fertility outcomes depend on factors such as age,
Geriatric & AYA Oncology
Fertility Preservation Before Cancer Treatment
Certain cancer treatments such as chemotherapy, radiotherapy, and pelvic surgery can impair fertility by damaging reproductive cells or hormonal pathways.
Treatment Strategy & Second Opinions
When to Seek Second Opinion In Cancer ?
A second opinion in cancer care is most valuable when a patient is newly diagnosed, when treatment decisions involve major
Precision Oncology
When Immunotherapy Works Even With Low PD-L1 Expression
While PD-L1 testing is widely used to guide immunotherapy decisions, a low or negative PD-L1 result does not necessarily mean
Precision Oncology
The Role of PD-L1 Testing Before Starting Immunotherapy
PD-L1 testing is an important biomarker assessment used to guide the use of immunotherapy in several cancers, particularly lung cancer
Disease-Specific Deep Dives
Molecular Subtypes of Breast Cancer and Their Treatment Implications
Molecular subtypes of Breast cancer is biologically classified using ER, PR, and HER2 status (and sometimes proliferation/genomic assays). These markers
Cancer Genetics & Hereditary Risk
When Should Patients Undergo Genetic Testing for Cancer Risk?
Genetic testing for cancer risk should be considered when personal or family history suggests a hereditary cancer syndrome. This includes
Precision Oncology
What Is Biomarker-Driven Therapy in Modern Oncology?
Biomarker-driven therapy is a precision oncology approach where cancer treatment is selected based on specific molecular characteristics of a tumor
Geriatric & AYA Oncology
Individualizing Cancer Treatment in the Elderly and Young Adults
Cancer treatment should not be determined by age alone. Elderly patients require physiologic assessment beyond chronological age, while adolescents and